Hepatotoxins Stocks List

Recent Signals

Date Stock Signal Type
2019-10-18 ATXI 180 Bearish Setup Bearish Swing Setup
2019-10-18 ATXI Calm After Storm Range Contraction
2019-10-18 ATXI 20 DMA Resistance Bearish
2019-10-18 ATXI 200 DMA Resistance Bearish
2019-10-18 ATXI Shooting Star Candlestick Bearish
2019-10-18 ATXI Doji - Bearish? Reversal
2019-10-18 ATXI 1,2,3 Retracement Bearish Bearish Swing Setup
2019-10-18 ATXI Slingshot Bearish Bearish Swing Setup
2019-10-18 ATXI Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-10-18 CPIX Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-10-18 CPIX Crossed Above 50 DMA Bullish
2019-10-18 GILD Stochastic Sell Signal Bearish
2019-10-18 GILD 50 DMA Support Bullish
2019-10-18 HEPA Slingshot Bullish Bullish Swing Setup
2019-10-18 HEPA Calm After Storm Range Contraction
2019-10-18 PLXP Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-10-18 PLXP Narrow Range Bar Range Contraction
2019-10-18 PLXP NR7 Range Contraction
2019-10-18 SNY Stochastic Reached Overbought Strength
2019-10-18 SNY MACD Bullish Signal Line Cross Bullish

Hepatotoxicity (from hepatic toxicity) implies chemical-driven liver damage. Drug-induced liver injury is a cause of acute and chronic liver disease.
The liver plays a central role in transforming and clearing chemicals and is susceptible to the toxicity from these agents. Certain medicinal agents, when taken in overdoses and sometimes even when introduced within therapeutic ranges, may injure the organ. Other chemical agents, such as those used in laboratories and industries, natural chemicals (e.g., microcystins) and herbal remedies can also induce hepatotoxicity. Chemicals that cause liver injury are called hepatotoxins.
More than 900 drugs have been implicated in causing liver injury (see LiverTox, external link, below) and it is the most common reason for a drug to be withdrawn from the market. Hepatotoxicity and drug-induced liver injury also account for a substantial number of compound failures, highlighting the need for toxicity prediction models (e.g. DTI), and drug screening assays, such as stem cell-derived hepatocyte-like cells, that are capable of detecting toxicity early in the drug development process. Chemicals often cause subclinical injury to the liver, which manifests only as abnormal liver enzyme tests.
Drug-induced liver injury is responsible for 5% of all hospital admissions and 50% of all acute liver failures.

More about Hepatotoxins